Daniel Griffin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19 (NCT04656691) | Daniel Griffin | 2021-01-04 |
Track Daniel Griffin automatically
Every clearance here is in the API, with alerts when new ones post.